Search Results - "Burge M"

Darkness Metaphors for Depression: A Case of Impaired Non-Visual Photoreception?

Authors: Burge, M. McGlashan, E. Sargeant, S. et al.

Source: Sleep Medicine. 2026 Supplement, Vol. 138, pN.PAG-N.PAG. 1p.

Blue light influences loss aversion.

Authors: Lander, A. Burge, M. Thomas, B. et al.

Source: Sleep Medicine. 2026 Supplement, Vol. 138, pN.PAG-N.PAG. 1p.

This result is not displayed to guests.
Login for full access.

A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.

Authors: Burge, M. E. Smith, D. Topham, C. et al.

Source: British Journal of Cancer. 5/8/2006, Vol. 94 Issue 9, p1281-1286. 6p. 6 Charts.

Retrospective review of pemetrexed with or without platinum in malignant mesothelioma: The Australian‘Special Access Scheme’ experience.

Authors: Burge, M. E. Joshua, A. M. McNeil, C. M. et al.

Source: Asia Pacific Journal of Clinical Oncology. Mar2005, Vol. 1 Issue 1, p47-52. 6p. 4 Charts, 2 Graphs.

A Minimal Line Property Preserving Representation of Line Images.

Authors: Burge, M. Kropatsch, W. G.

Source: Computing; 1999, Vol. 62 Issue 4, p355, 14p

Circadian photoreception impacts thoughts of self.

Authors: Burge, M. Lumapas, R. Lander, A. et al.

Source: Sleep Medicine. Feb2024:Supplement 1, Vol. 115, pN.PAG-N.PAG. 1p.

What are the barriers to medical care for patients with newly diagnosed diabetes mellitus?

Authors: Burge, M. R. Lucero, S. Rassam, A. G. et al.

Source: Diabetes, Obesity & Metabolism. Dec2000, Vol. 2 Issue 6, p351-354. 4p. 1 Diagram, 1 Chart.

Some Aspects of Administration in the International Labour Office.

Authors: Burge, M. R. K.¹

Source: Public Administration. Mar1945, Vol. 23 Issue 1, p21-31. 11p.

THE BRITISH COUNCIL.

Authors: Burge, M. R. K.

Source: Political Quarterly. Oct1945, Vol. 16 Issue 4, p307-315. 9p.

Effects of estradiol on substrate turnover during exercise in amenorrheic females.

Authors: Ruby, B.C. Robergs, R.A. Waters, D.L. et al.

Source: Medicine & Science in Sports & Exercise. Sept 1997: Vol. 29 Issue 9. p. 1160-1169-1169.

107P Safety and efficacy of trifluridine/tipiracil (FTD/TPI) in previously treated metastatic colorectal cancer (mCRC): Results from the Australian cohort of the phase IIIb, international, open-label, early-access PRECONNECT study.

Authors: Price, T.J. Burge, M. Chantrill, L. et al.

Source: Annals of Oncology. 2020 Supplement 6, Vol. 31, pS1283-S1283. 1p.

Lack of compliance with home blood glucose monitoring predicts hospitalization in diabetes.

Authors: BURGE, MARK R. Burge, M R

Source: Diabetes Care. Aug2001, Vol. 24 Issue 8, p1502-1503. 2p.

Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma.

Authors: Mercieca-Bebber, R. Barnes, E. H. Wilson, K. et al.

Source: BMC Cancer. 3/15/2022, Vol. 22 Issue 1, p1-11. 11p.

Effect of immediate-release glipizide on hypoglycemic vulnerability in fasted, elderly patients with type 2 diabetes.

Authors: Burge, M R Schmitz-Fiorentino, K Sood, V et al.

Source: JAMA: Journal of the American Medical Association. 3/24/99, Vol. 281 Issue 12, p1084-1085. 2p.

This result is not displayed to guests.
Login for full access.

Lack of immune barrier to allogeneic hematopoietic stem cell engraftment in T, B, and NK cell deficient (Rag2γc^−/−B6) mice

Authors: Logronio, K.A. Burge, M. Shizuru, J.

Source: Biology of Blood & Marrow Transplantation. Feb2006 Supplement 1, Vol. 12, p26-26. 1p.

Mycoherbicide formulation and the potential for bracken control

Authors: Burge, M. N. Womack, J. G.

Source: Pesticide Science. 1993, Vol. 37 Issue 4, p337. 0p.

The morphology, physiology and pathogenicity of Cephalosporium asteris Dowson

Authors: Burge, M. N.

URL: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.636176

2219P AGITG ASCEND: Randomised, double-blind phase II trial of certepetide (CERT) or placebo (PLA) with gemcitabine (Gem) + nab-paclitaxel (Nab) in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC): Updated results including planned pooled placebo analysis

Authors: Dean, A. Harris, M.T. Sjoquist, K. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1233-S1234. 2p.